350 related articles for article (PubMed ID: 16866364)
1. Structural insights into the interaction between prion protein and nucleic acid.
Lima LM; Cordeiro Y; Tinoco LW; Marques AF; Oliveira CL; Sampath S; Kodali R; Choi G; Foguel D; Torriani I; Caughey B; Silva JL
Biochemistry; 2006 Aug; 45(30):9180-7. PubMed ID: 16866364
[TBL] [Abstract][Full Text] [Related]
2. Preventing misfolding of the prion protein by trimethylamine N-oxide.
Bennion BJ; DeMarco ML; Daggett V
Biochemistry; 2004 Oct; 43(41):12955-63. PubMed ID: 15476389
[TBL] [Abstract][Full Text] [Related]
3. Generation of genuine prion infectivity by serial PMCA.
Weber P; Giese A; Piening N; Mitteregger G; Thomzig A; Beekes M; Kretzschmar HA
Vet Microbiol; 2007 Aug; 123(4):346-57. PubMed ID: 17493773
[TBL] [Abstract][Full Text] [Related]
4. Binding of recombinant PrPc to human plasminogen: kinetic and thermodynamic study using a resonant mirror biosensor.
Cuccioloni M; Amici M; Eleuteri AM; Biagetti M; Barocci S; Angeletti M
Proteins; 2005 Feb; 58(3):728-34. PubMed ID: 15609351
[TBL] [Abstract][Full Text] [Related]
5. Peptides and proteins in neurodegenerative disease: helix propensity of a polypeptide containing helix 1 of the mouse prion protein studied by NMR and CD spectroscopy.
Liu A; Riek R; Zahn R; Hornemann S; Glockshuber R; Wüthrich K
Biopolymers; 1999; 51(2):145-52. PubMed ID: 10397798
[TBL] [Abstract][Full Text] [Related]
6. Structuring the puzzle of prion propagation.
Eghiaian F
Curr Opin Struct Biol; 2005 Dec; 15(6):724-30. PubMed ID: 16263262
[TBL] [Abstract][Full Text] [Related]
7. Prion-protein-specific aptamer reduces PrPSc formation.
Proske D; Gilch S; Wopfner F; Schätzl HM; Winnacker EL; Famulok M
Chembiochem; 2002 Aug; 3(8):717-25. PubMed ID: 12203970
[TBL] [Abstract][Full Text] [Related]
8. The emerging principles of mammalian prion propagation and transmissibility barriers: Insight from studies in vitro.
Surewicz WK; Jones EM; Apetri AC
Acc Chem Res; 2006 Sep; 39(9):654-62. PubMed ID: 16981682
[TBL] [Abstract][Full Text] [Related]
9. Physical studies of conformational plasticity in a recombinant prion protein.
Zhang H; Stockel J; Mehlhorn I; Groth D; Baldwin MA; Prusiner SB; James TL; Cohen FE
Biochemistry; 1997 Mar; 36(12):3543-53. PubMed ID: 9132005
[TBL] [Abstract][Full Text] [Related]
10. The state of the prion.
Weissmann C
Nat Rev Microbiol; 2004 Nov; 2(11):861-71. PubMed ID: 15494743
[TBL] [Abstract][Full Text] [Related]
11. Screening a library of potential prion therapeutics against cellular prion proteins and insights into their mode of biological activities by surface plasmon resonance.
Touil F; Pratt S; Mutter R; Chen B
J Pharm Biomed Anal; 2006 Mar; 40(4):822-32. PubMed ID: 16242887
[TBL] [Abstract][Full Text] [Related]
12. Solution structure of Syrian hamster prion protein rPrP(90-231).
Liu H; Farr-Jones S; Ulyanov NB; Llinas M; Marqusee S; Groth D; Cohen FE; Prusiner SB; James TL
Biochemistry; 1999 Apr; 38(17):5362-77. PubMed ID: 10220323
[TBL] [Abstract][Full Text] [Related]
13. Mapping of possible prion protein self-interaction domains using peptide arrays.
Rigter A; Langeveld JP; Timmers-Parohi D; Jacobs JG; Moonen PL; Bossers A
BMC Biochem; 2007 Apr; 8():6. PubMed ID: 17430579
[TBL] [Abstract][Full Text] [Related]
14. Molecular model of an alpha-helical prion protein dimer and its monomeric subunits as derived from chemical cross-linking and molecular modeling calculations.
Kaimann T; Metzger S; Kuhlmann K; Brandt B; Birkmann E; Höltje HD; Riesner D
J Mol Biol; 2008 Feb; 376(2):582-96. PubMed ID: 18158160
[TBL] [Abstract][Full Text] [Related]
15. Assembly of natural and recombinant prion protein into fibrils.
Leffers KW; Wille H; Stöhr J; Junger E; Prusiner SB; Riesner D
Biol Chem; 2005 Jun; 386(6):569-80. PubMed ID: 16006244
[TBL] [Abstract][Full Text] [Related]
16. Semiautomated cell-free conversion of prion protein: applications for high-throughput screening of potential antiprion drugs.
Breydo L; Bocharova OV; Baskakov IV
Anal Biochem; 2005 Apr; 339(1):165-73. PubMed ID: 15766724
[TBL] [Abstract][Full Text] [Related]
17. Experimental approaches to the interaction of the prion protein with nucleic acids and glycosaminoglycans: Modulators of the pathogenic conversion.
Silva JL; Vieira TC; Gomes MP; Rangel LP; Scapin SM; Cordeiro Y
Methods; 2011 Mar; 53(3):306-17. PubMed ID: 21145399
[TBL] [Abstract][Full Text] [Related]
18. The role of rafts in the fibrillization and aggregation of prions.
Pinheiro TJ
Chem Phys Lipids; 2006 Jun; 141(1-2):66-71. PubMed ID: 16647049
[TBL] [Abstract][Full Text] [Related]
19. Prion and doppel proteins bind to granule cells of the cerebellum.
Legname G; Nelken P; Guan Z; Kanyo ZF; DeArmond SJ; Prusiner SB
Proc Natl Acad Sci U S A; 2002 Dec; 99(25):16285-90. PubMed ID: 12446843
[TBL] [Abstract][Full Text] [Related]
20. The highways and byways of prion protein trafficking.
Campana V; Sarnataro D; Zurzolo C
Trends Cell Biol; 2005 Feb; 15(2):102-11. PubMed ID: 15695097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
